Differentiation potential of histocompatible parthenogenetic embryonic stem cells

Annals of the New York Academy of Sciences

Volumn 1106, Issue , 2007, Pages 209-218

  Lengerke, Claudia ^a,b,c   Kim, Kitai ^a,b,c   Lerou, Paul ^a,c,d   Daley, George Q ^a,b,c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Developmental potential; Embryonic stem cells; Igf2; MHC matched; Parthenogenesis

Indexed keywords

BLASTOCYST; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS TRANSPLANTATION; CONFERENCE PAPER; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC RECOMBINATION; HETEROZYGOSITY; HISTOCOMPATIBILITY; HLA SYSTEM; IMMUNOCOMPETENT CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OOCYTE; PARTHENOGENESIS; SOMATIC CELL THERAPY; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL NUCLEUS; CYTOLOGY; EMBRYO; FEMALE; HETEROZYGOTE; HISTOCOMPATIBILITY TEST; MALE; METABOLISM; MOUSE; SPERMATOZOON;

MURINAE; MUS;

ANIMALS; BLASTOCYST; CELL DIFFERENTIATION; CELL NUCLEUS; EMBRYO; EMBRYONIC STEM CELLS; FEMALE; HETEROZYGOTE; HISTOCOMPATIBILITY TESTING; MALE; MICE; MODELS, BIOLOGICAL; NUCLEAR TRANSFER TECHNIQUES; PARTHENOGENESIS; SPERMATOZOA;

EID: 34547922089     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1392.011     Document Type: Conference Paper

References (28)

1. ROUGIER, N. & Z. WERB. 2001. Minireview: parthenogenesis in mammals. Mol. Reprod. Dev. 59: 468-474.
2. KONO, T. et al. 2004. Birth of parthenogenetic mice that can develop to adulthood. Nature. 428: 860-864.
3. THOMSON, J.A. & D. SOLTER. 1988. The developmental fate of androgenetic, parthenogenetic, and gynogenetic cells in chimeric gastrulating mouse embryos. Genes Dev. 2: 1344-1351.
4. LEE, G.H. et al. 1997. Genetic dissection of susceptibility to murine ovarian teratomas that originate from parthenogenetic oocytes. Cancer Res. 57: 590-593.
5. LINDER, D., B.K. MCCAW & F. HECHT. 1975. Parthenogenic origin of benign ovarian teratomas. N. Engl. J. Med. 292: 63-66.
6. STEVENS, L.C. & D.S. VARNUM. 1974. The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev. Biol. 37: 369-380.
7. WAKE, N., N. TAKAGI & M. SASAKI. 1978. Androgenesis as a cause of hydatidiform mole. J. Natl. Cancer Inst. 60: 51-57.
8. CIBELLI, J.B., K. CUNNIFF & K.E. VRANA. 2006. Embryonic stem cells from parthenotes. Methods Enzymol. 418: 117-135.
9. KIM, K. et al. 2007. Histocompatible embryonic stem cells by parthenogenesis. Science 315(5811): 482-486. Epub 2006 Dec. 14.
10. KYBA, M., R.C. PERLINGEIRO & G.Q. DALEY. 2002. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109: 29-37.
11. SANCHEZ-PERNAUTE, R. et al. 2005. Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells 23: 914-922.
12. VRANA, K.E. et al. 2003. Nonhuman primate parthenogenetic stem cells. Proc. Natl. Acad. Sci. USA 100 (Suppl 1): 11911-11916.
13. NAGY, A., M. SASS & M. MARKKULA. 1989. Systematic non-uniform distribution of parthenogenetic cells in adult mouse chimaeras. Development 106: 321-324.
14. FUNDELE, R. et al. 1989. Systematic elimination of parthenogenetic cells in mouse chimeras. Development 106: 29-35.
15. CLARKE, H.J. et al. 1988. The development potential of parthenogenetically derived cells in chimeric mouse embryos: implications for action of imprinted genes. Development 104: 175-182.
16. NAGY, A. et al. 1987. Prenatal fate of parthenogenetic cells in mouse aggregation chimaeras. Development 101: 67-71.
17. BUCKINGHAM, M. et al. 2003. The formation of skeletal muscle: from somite to limb. J. Anat. 202: 59-68.
18. URANGA, J.A. & J. ARECHAGA. 1997. Cell proliferation is reduced in parthenogenetic mouse embryos at the blastocyst stage: a quantitative study. Anat. Rec. 247: 243-247.
19. MCKARNEY, L.A., M.L. OVERALL & M. DZIADEK. 1997. Myogenesis in cultures of uniparental mouse embryonic stem cells: differing patterns of expression of myogenic regulatory factors. Int. J. Dev. Biol. 41: 485-490.
20. MANN, J.R. et al. 1990. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 62: 251-260.
21. DECHIARA, T.M., E.J. ROBERTSON & A. EFSTRATIADIS. 1991. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64: 849-859.
22. DECHIARA, T.M., A. EFSTRATIADIS & E.J. ROBERTSON. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80.
23. STEWART, C.E. et al. 1996. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation. J. Cell. Physiol. 169: 23-32.
24. STEWART, C.E. & P. ROTWEIN. 1996. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271: 11330-11338.
25. PRELLE, K. et al. 2000. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation. Biochem. Biophys. Res. Commun. 277: 631-638.
26. ALLEN, N.D. et al. 1994. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120: 1473-1482.
27. STRAIN, L. et al. 1995. A human parthenogenetic chimaera. Nat. Genet. 11: 164-169.
28. TAYLOR, C.J. et al. 2005. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366: 2019-2025.